David Milligan, M.D. Net Worth & Insider Trades
David Milligan, M.D. - Director, Madrigal Pharmaceuticals, Inc
What is David Milligan, M.D.'s Net Worth?
The current estimated net worth of Madrigal Pharmaceuticals, Inc's Director, David Milligan, M.D., is estimated to be about $6.38M . David Milligan, M.D. owns about 20,000 units of Madrigal Pharmaceuticals, Inc common stock. In the last 5 years at Madrigal Pharmaceuticals, Inc, David Milligan, M.D. has sold an estimated value of $3.57M worth.
What is David Milligan, M.D.'s Past Insider Trading?
David Milligan, M.D.'s largest sale order was 20,000 units , worth over $2.25M on February 26, 2020. In total, David Milligan, M.D. has made about 9 transactions over 5 years of their time at Madrigal Pharmaceuticals, Inc. David Milligan, M.D. usually trades in June, with the busiest year in 2018 and 2020. The most recent transaction was a sale order of 10,000 units , worth over $1.32M on February 26, 2020.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
David Milligan, M.D.
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is David Milligan, M.D.'s' Mailing Address?
- Mailing address is 801 Interlaken Ln. Libertyville IL 60048 IL
Madrigal Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Option Awards
|
Other Earnings Plans or Compensations
|
Bonus
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Paul A. Friedman, M.D. | 2020 | $603,500 | $3,468,500 | $463,446 | - | - | $4,535,446 |
| Paul A. Friedman, M.D. | 2019 | $584,000 | $5,122,000 | $387,192 | - | - | $6,093,192 |
| Paul A. Friedman, M.D. | 2018 | $416,666 | $4,907,500 | $304,500 | - | - | $5,628,666 |
| Rebecca Taub, M.D. | 2020 | $490,833 | $3,052,280 | $339,230 | - | - | $3,882,343 |
| Rebecca Taub, M.D. | 2019 | $463,948 | $4,531,120 | $274,775 | - | - | $5,269,843 |
| Rebecca Taub, M.D. | 2018 | $385,416 | $3,729,700 | $225,330 | - | - | $4,340,446 |
| Remy Sukhija | 2020 | $337,500 | $2,724,000 | $274,680 | $100,000 | $2,722 | $3,438,902 |
| Marc R. Schneebaum | 2020 | $435,000 | $2,219,840 | $267,233 | - | $18,399 | $2,940,472 |
| Marc R. Schneebaum | 2019 | $421,000 | $2,868,320 | $223,298 | - | $20,034 | $3,532,652 |
| Marc R. Schneebaum | 2018 | $380,250 | $2,748,200 | $222,314 | - | $15,336 | $3,366,100 |
| Brian J. Lynch | 2020 | $425,417 | $3,749,840 | $260,946 | - | $11,690 | $4,447,893 |
| Brian J. Lynch | 2019 | $358,602 | $3,506,859 | $192,602 | - | $10,574 | $4,068,637 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1157601/000119312521144922/d107927ddef14a.htm
What are Madrigal Pharmaceuticals, Inc's Past Insider Trades?
Madrigal Pharmaceuticals, Inc's most recent insider trade came on December 6, 2023 by Brian J. Lynch who sold 2,800 units worth $621.29K . In the last 6 years, insiders at Madrigal Pharmaceuticals, Inc have sold an estimated value of $472.07M and bought an estimated value of $80.52M worth of shares. Insider trading is most common in June, with the busiest year in 2023. The most active traders at the company are Fred Craves, Director, Richard Levy, Director, and David Milligan, M.D., Director .
MADRIGAL PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||